Brain infarction is one of the most important ageassociated diseases. We have developed aged animal models for brain ischemia, and found the age-related neuronal vulnerability to brain ischemia. Investigation of that mechanism would lead to the effective treatment of brain infarction in the elder population. Recent advancement of gene transfer technique has provided strong tools for the neuronal and vascular biology. We described our recent approaches of gene transfer to blood vessels, including cerebral circulation, using adenoviral vectors. Cerebral blood vessels, atheroscierotic endothelium, and ischemic brain tissue are good targets of gene transfer. Development of these techniques would offer new therapeutic strategies for the age-related neuronal vulnerability and other age-associated diseases.
Aged model for ischemic stroke
Stroke is the leading cause of death in the Japanese elderly [1] , and aging is known as main risk factors for stroke [2] and vascular dementia [3] . Although aged models for the experimental brain ischemia have been claimed to be important [4] , the studies using such models are limited.
Recently, we have developed the experimental model for brain ischemia with aged spontaneously hypertensive rats (SHR), more relevant models for human stroke [5] . Using this model, we demonstrated that the hippocampus in the aged rats was more susceptible to transient cerebral ischemia than that in the adult (Figure 1 ). Other investigators also reported that embolic brain damages in the aged animals were severer than in the young animals [6] . Our study revealed that reduction of perfusion pressure to the brain was similar between the adult and aged SHR, suggesting that factors other than blood flow may affect the ischemic damages in the aged
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Excitotoxicity
Although brain is the most susceptible organ to ischemia, there are more vulnerable cerebral tissues, such as hippocampal pyramidal cells, medium-sized cells in the striatum and pyramidal cell layers in the cortex [7] . Pathophysiology of these selective vulnerability to ischemia has been an important research subject.
One strong hypothesis for the selective neuronal vulnerability is the excitotoxicity theory [8] . Excitatory amino acids, such as glutamate and aspartate, have been proposed to play pivotal roles in neurotoxicity, and increases in extracellular excitatory amino acids during cerebral ischemia were observed in the vulnerable areas [9] . The specific receptors for excitatory amino acids, i.e., N-methyI-D-aspartate (NMDA), ~-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) and metabotropic receptors, locate at those vulnerable areas, and these receptors are reported to play important roles in neuronal death. Hippocampal CA1 subfield is the most energetically studied areas in regard to the selective vulnerability, and is known for its unique response to transient ischemia, called "delayed neuronal death" [10] . In relation to NMDA receptor complex, glycine also plays an important role in the pathophysiology of ischemic cell damage [11] . Furthermore, inhibitory amino acids, e.g., ~-aminobutydc acid (GABA) and taurine, are reported to protect against ischemic damages [12, 13] .
Age-related ischemic vulnerability
As we described in the earlier part, aged brains are more susceptible to ischemia than adult ones [5] . The mechanism of this age-related ischemic vulnerability is still not clear. We examined involvement of extracellular excitatory and inhibitory amino acids in the hippocampus where the vulnerability is most obvious [14] . Interestingly, there were no significant differences in ischemiainduced changes in excitatory amino acids between aged and young animals. In contrast, smaller increases of extracellular taurine during ischemia were observed in the aged animals. Therefore, balances of excitatory and inhibitory amino acids may play a critical role in the age-related vulnerability. i Mild brain hypothermia is reported to have marked neuroprotection against ischemic insults in the adult animals [15, 16] . However, effects of hypothermia on the ischemic damage in the aged animals have not been well clarified. We examined effects of brain hypothermia on the age-related brain damage to ischemia. Even small reduction of brain temperature (by 3~ reduction) during brain ischemia markedly attenuated ischemic damage in the hippocampus (Figure 1 ). Therefore, mild brain hypothermia may be one of the promising approach for treatment of brain infarction in the elder population, although safety of this approach is an important issue.
Gene transfer to blood vessels
Gene transfer is an attractive method for studies of vascular and neuronal biology. Clinical use of this technique, namely gene therapy, may be a promising approach for many disorders [17] . One of the most useful vectors for gene transfer is the recombinant adenovirus [18] . The vector consists of 36 kilo base DNA inside the capsid protein. Because the vector has a wide host rage and great efficiency of gene transfer without relation to malignancy, many clinical trials utilize this vector [19, 20] .
For gene transfer to blood vessels, intravascular administration of the vector using special catheters is a common approach [21] . In that case, needs of stopping blood flow may be a critical limitation in the cerebral circulation. Therefore, we have examined efficacy of an alternative method, perivascular approach [22, 23] . To deliver the foreign gene to cerebral blood vessels, we administered an adenoviral vectors encoding cDNA of bacterial B-galactosidase as a reporter gene into cerebrospinal fluid (CSF) via the cisterna magna [24] . This vector is a replication deficient because the E1 region that is necessary for viral replication is deleted. One day after vector injection, the reporter gene efficiently expressed around the circle of Willis. When the vector was administered in a lateral position, transgene expression was mainly observed around the middle cerebral artery (Figure 2) . Using mice models, we also observed good efficiency of gene transfer to the cerebral blood vessels [25] . Therefore, our perivascular approach via CSF provides efficient gene transfer to cerebral blood vessels. One of the possible clinical application of this approach is prevention of vasospasm after subarachnoid hemorrhage. Vasospasm occurs several days after the bleeding, and this time course is suitable for expression of transgene. We examine the efficacy of gene transfer to the cerebral blood vessels after subarachnoid hemorrhage in dogs, using the above-mentioned perivascular approach. Two to seven days after injection of the vector, prominent expression of the reporter gene was observed even in the presence of subarachnoid hemorrhage [26] . Transfer of the vasodilating gene using this method was effective in preventing vasospasm in rabbits [27] . Therefore, perivascular approaches to the cerebral blood vessels may be useful in gene therapy for subarachnoid hemorrhages.
Atherosclerotic lesion is an important therapeutic target in the aged populations. Efficiency of gene transfer to the atherosclerotic vessel is an important issue, because low efficiency was reported in a rabbit's model of angioplasty [28] . Therefore, we examined the efficacy of gene transfer to the endothelium of atherosclerotic vessels using cholesterol-fed monkeys [29] . One day after transfection to excised aorta, expression of the reporter gene was observed in both endothelium and adventitia. Interestingly, transgene expression in the atherosclerotic endothelium was much greater than that in the normal endothelium. Augmented expression in the atherosclerotic vessels was also observed in the aorta from cholesterol-fed rabbits and the carotid and basilar arteries from Watanabe heritable hyperlJpJdemic rabbits as well [30] . We have shown that gene transfer of endothelial nitric oxide synthase gene to the carotid arteries of rabbits augments vascular responses to the vasodilating stimuli in both normal and atherosclerotic vessels [31, 32] . Therefore, atherosclerotic endothelium may be a good target for gene therapy.
For the in vivo gene transfer to the endothelium, the intravascular approach is essential. To minimize complications associated with cessation of blood flow to the vital organ, it is important to improve efficiency of gene transfer technique itself. One of the promising approaches is the combination of cationic materials with viral vectors [33] . We found that mixture of adenoviral vectors with cationic lipid or cationic polymers (poly-Llysine) improved efficiency of gene transfer (Figure 3 ). These technological advancement would make it possible to use the intravascular approach for gene transfer to cerebral blood vessels. 
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Gene transfer to ischemic brain
Machinery of protein synthesis is impaired in the ischemic conditions. The protein synthesis starts to decrease when cerebral blood flow (CBF) declines to less than 50% [34, 35] . Therefore, it is important to know how brain ischemia affects the efficiency of gene transfer. We examined effects of focal brain ischemia on transgene expression [36] . We have developed an ischemic model of photothrombotic occlusion of the distal middle cerebral artery of SHR, which produces a consistent size of brain infarction [37] . The adenoviral vector carrying the reporter gene was directly injected into ischemic and non-ischemic regions ninety minutes after induction of focal ischemia. Expression of the reporter gene was detected through 1 to 7 days after ischemia at contralateral hemisphere and adjacent nonJschemic regions. Microscopic examination revealed that expression of the reporter gene was observed in neurons and non-neuronal cells. The peri-ischemic area, the presumable ischemic penumbra in our model, also revealed relatively good expression. However, transgene expression was poor in the ischemic core.
Analysis of blood flow at the penumbra area revealed that CBF threshold for transgene expression was approximately 40% of the resting value. Therefore, gene transfer to the ischemic penumbra zone may be feasible for treatment of brain infarction.
Gene transfer to aged brainpotential target of gene therapy
Adenovirus-mediated gene transfer provides efficient transgene expression in the cerebral blood vessels, atherosclerotic vessels and ischemic brains. Although we need to overcome the obstacles of safety and efficiency, gene transfer to the cerebral circulation may be one of the promising approaches to cerebrovascular disease. Recent our study suggests that gene transfer to aged ischemic brain is more efficient than to the adult ones (unpublished data). Therefore, gene therapy to the aged brain, including brain infarction, may be feasible, and the new therapeutic approach may reduce or minimize disability in the aged population in the future.
